Citadel Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Buy
34,600
+8,700
+34% +$443K ﹤0.01% 6319
2025
Q4
$1.29M Buy
+25,900
New +$1.26M ﹤0.01% 6852
2025
Q2
Sell
-6,300
Closed -$206K 14995
2025
Q1
$206K Buy
6,300
+300
+5% +$10.6K ﹤0.01% 10384
2024
Q4
$217K Buy
6,000
+3,400
+131% +$120K ﹤0.01% 10299
2024
Q3
$81.1K Sell
2,600
-2,600
-50% -$81.1K ﹤0.01% 11394
2024
Q2
$139K Sell
5,200
-4,300
-45% -$125K ﹤0.01% 10455
2024
Q1
$324K Sell
9,500
-5,100
-35% -$152K ﹤0.01% 9286
2023
Q4
$423K Buy
14,600
+12,700
+668% +$337K ﹤0.01% 8459
2023
Q3
$52.4K Sell
1,900
-500
-21% -$15.2K ﹤0.01% 11706
2023
Q2
$72.1K Buy
2,400
+1,400
+140% +$49K ﹤0.01% 11357
2023
Q1
$36.2K Buy
1,000
+800
+400% +$30.8K ﹤0.01% 12549
2022
Q4
$7.13K Buy
+200
New +$6.95K ﹤0.01% 13848
2022
Q2
Sell
-10,400
Closed -$336K 14067
2022
Q1
$336K Sell
10,400
-3,600
-26% -$110K ﹤0.01% 10328
2021
Q4
$408K Buy
14,000
+4,100
+41% +$124K ﹤0.01% 10167
2021
Q3
$264K Sell
9,900
-20,100
-67% -$540K ﹤0.01% 11348
2021
Q2
$924K Buy
30,000
+9,900
+49% +$304K ﹤0.01% 8572
2021
Q1
$526K Sell
20,100
-2,800
-12% -$78.3K ﹤0.01% 9570
2020
Q4
$576K Sell
22,900
-7,600
-25% -$164K ﹤0.01% 7885
2020
Q3
$636K Buy
+30,500
New +$692K ﹤0.01% 6851
2020
Q1
Sell
-14,300
Closed -$339K 10153
2019
Q4
$339K Buy
14,300
+1,600
+13% +$38.9K ﹤0.01% 7405
2019
Q3
$349K Sell
12,700
-8,800
-41% -$261K ﹤0.01% 7341
2019
Q2
$711K Sell
21,500
-13,900
-39% -$476K ﹤0.01% 6255
2019
Q1
$1.24M Buy
35,400
+19,000
+116% +$707K ﹤0.01% 5217
2018
Q4
$545K Sell
16,400
-22,600
-58% -$972K ﹤0.01% 6277
2018
Q3
$1.96M Buy
39,000
+7,200
+23% +$356K ﹤0.01% 4439
2018
Q2
$1.9M Buy
31,800
+18,500
+139% +$958K ﹤0.01% 4193
2018
Q1
$609K Sell
13,300
-6,800
-34% -$284K ﹤0.01% 5562
2017
Q4
$801K Sell
20,100
-4,300
-18% -$170K ﹤0.01% 4972
2017
Q3
$976K Buy
24,400
+17,900
+275% +$775K ﹤0.01% 4356
2017
Q2
$280K Sell
6,500
-7,600
-54% -$270K ﹤0.01% 6012
2017
Q1
$441K Buy
14,100
+4,400
+45% +$118K ﹤0.01% 5234
2016
Q4
$245K Buy
9,700
+700
+8% +$15.6K ﹤0.01% 5976
2016
Q3
$223K Buy
+9,000
New +$204K ﹤0.01% 6159
2016
Q1
Sell
-19,600
Closed -$263K 7903
2015
Q4
$263K Sell
19,600
-3,600
-16% -$55.7K ﹤0.01% 5418
2015
Q3
$325K Buy
23,200
+9,400
+68% +$175K ﹤0.01% 5448
2015
Q2
$234K Buy
13,800
+6,200
+82% +$88.2K ﹤0.01% 6107
2015
Q1
$92K Sell
7,600
-3,900
-34% -$36.9K ﹤0.01% 6901
2014
Q4
$95K Sell
11,500
-100
-0.9% -$840 ﹤0.01% 6681
2014
Q3
$101K Sell
11,600
-17,600
-60% -$159K ﹤0.01% 6409
2014
Q2
$320K Sell
29,200
-21,700
-43% -$193K ﹤0.01% 4994
2014
Q1
$455K Buy
50,900
+30,300
+147% +$279K ﹤0.01% 4472
2013
Q4
$155K Buy
20,600
+19,000
+1,188% +$133K ﹤0.01% 5257
2013
Q3
$12K Buy
+1,600
New +$10.7K ﹤0.01% 6426

Other funds holding SUPN